Superworth

Starling Oncology EPS STLN

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$0.30
Latest quarter, Q2 FY26
−$0.08
Fiscal year 2025
−$0.56

Starling Oncology's earnings per share was −$0.30 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.08.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.56n/a
FY2024−$0.71n/a
FY2023−$0.92n/a
FY2022−$0.14n/a
FY2021−$0.25n/a
FY2020−$0.55n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.08n/a−$0.30
Q1 FY26−$0.02n/a−$0.37
Q4 FY25−$0.06n/a−$0.56
Q3 FY25−$0.14n/a−$0.64
Q2 FY25−$0.15n/a−$0.68
Q1 FY25−$0.21n/a−$0.70
Q4 FY24−$0.14n/a−$0.71
Q3 FY24−$0.18n/a−$0.78
Q2 FY24−$0.17n/a−$0.79
Q1 FY24−$0.22n/a−$0.81
Q4 FY23−$0.21n/a−$0.92
Q3 FY23−$0.19n/a−$0.83

Against its peers

Companies in Medical - Care Facilities nearest Starling Oncology's size, closest first, today.

CompanyEPS, 12 monthsGrowth
STLNStarling Oncology−$0.30
SBCSBC Medical$0.47+47% a year
OMDAOmada Health$0.06
VMDViemed Healthcare$0.36+6% a year
USPHU S Physical Therapy$0.88−63% a year
PNTGPennant$0.90+15% a year
ARDTArdent Health$0.55−70% a year
HCSGHealthcare Services$1.72+176% a year
PGNYProgyny$0.92+56% a year
ADUSAddus HomeCare$5.70+26% a year
MDPediatrix Medical$2.09+62% a year
Peer median$0.89

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Starling Oncology

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.